ATR
APTARGROUP, INC.
NYSE · Healthcare · Medical - Instruments & Supplies · US
$124.44
−0.84%Next report
Analyst consensus
- Next report date
- Oct 29, 2026
- EPS estimate
- $1.46
- Revenue estimate
- $986.0M
Latest reported
- Last report date
- Jul 31, 2026
- EPS actual
- $1.42
- EPS estimate
- $1.36
- Revenue actual
- $1.0B
- Revenue estimate
- $1.0B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 10
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- +2.8%
- Revenue beats (12Q)
- 5
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 31, 2026 | $1.36 | $1.42 | Beat 4.64% | $1.0B |
| May 1, 2026 | $1.15 | $1.19 | Beat 3.39% | $982.9M |
| Feb 5, 2026 | $1.25 | $1.25 | Beat 0.08% | $962.7M |
| Oct 30, 2025 | $1.57 | $1.62 | Beat 3.05% | $961.1M |
| Jul 31, 2025 | $1.58 | $1.66 | Beat 5.20% | $966.0M |
| May 1, 2025 | $1.17 | $1.20 | Beat 2.83% | $887.3M |
| Feb 6, 2025 | $1.28 | $1.52 | Beat 18.47% | $848.1M |
| Oct 24, 2024 | $1.43 | $1.49 | Beat 4.41% | $909.3M |
| Jul 25, 2024 | $1.37 | $1.37 | Beat 0.29% | $910.1M |
| Apr 25, 2024 | $1.15 | $1.26 | Beat 9.47% | $915.4M |
| Feb 8, 2024 | $1.12 | $1.21 | Beat 8.13% | $838.5M |
| Oct 25, 2023 | $1.26 | $1.39 | Beat 9.88% | $893.0M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 29, 2026